TransMedics Group, Inc. (TMDX): Capital Expenditures

Annual figures by period end, from SEC filings.

$59.25M
Year ended 2025-12-31
$66.89M
Trailing 12 months to 2026-06-30
+70.7%
3-year compound annual growth
n/m
5-year compound annual growth
$151.85M2018-12-29: $418.0K2019-12-28: $165.0K2020-12-31: $455.0K2021-12-31: $3.52M2022-12-31: $11.91M2023-12-31: $151.85M2024-12-31: $129.74M2025-12-31: $59.25M$59.25M
2018-12-29 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$59.25M-54.3%2026-02-24, From 2025-01-01
2024-12-31$129.74M-14.6%2026-02-24, From 2024-01-01
2023-12-31$151.85Mn/m2026-02-24, From 2023-01-01
2022-12-31$11.91M+238.4%2025-02-27, From 2022-01-01
2021-12-31$3.52M+673.4%2024-02-27, From 2021-01-01
2020-12-31$455.0K+175.8%2023-02-27, From 2019-12-29
2019-12-28$165.0K-60.5%2021-03-11, From 2018-12-30
2018-12-29$418.0Kn/a2020-03-17, From 2017-12-31

Capital Expenditures at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
TransMedics Group, Inc. (TMDX)2025-12-31$59.25M-54.3%
InMode Ltd. (INMD)2025-12-31$972.0K+45.3%
Conmed Corp (CNMD)2025-12-31$19.81M+51.4%
LivaNova PLC (LIVN)2025-12-31$81.05M+72.1%
Axogen, Inc. (AXGN)2025-12-31$3.75M+20.8%
Integer Holdings Corp (ITGR)2025-12-31$91.03M-13.6%
Outset Medical, Inc. (OM)2025-12-31$798.0K-12.5%
Biolife Solutions Inc (BLFS)2025-12-31$9.48M+193.7%
Ceribell, Inc. (CBLL)2025-12-31$767.0K-42.8%

Compare TMDX, INMD, CNMD, LIVN side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗